Cisplatin efficacy
WebApr 5, 2024 · This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer. Condition or disease ... such as envafolimab and cisplatin; Subjects who have concomitant diseases that, in the ... WebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. ... 11 with an overall five-year survival of just 16%. 12 Therefore, improving the efficacy of DDP chemotherapy and sequential treatment after the failure of the DDP chemotherapy is crucial to ...
Cisplatin efficacy
Did you know?
WebNov 17, 2024 · Cisplatin has been widely used for a variety of cancer chemotherapies. In the guidelines for CINV, cisplatin is classified as a high-emetic-risk antineoplastic agent, and several agents – i.e. NK1 receptor antagonist (NK1RA), dexamethasone and 5-hydroxytryptamine-3 receptor antagonist (5-HT3RA) – are recommended for use with … WebApr 11, 2024 · To evaluate if STAT3 KD can enhance the efficacy of cisplatin therapy for MB, we treated HD-shSTAT3 and ONS-shSTAT3 cells with an increasing concentration …
Webotoprotective effect, with maximum efficacy oc-curring when sodium thiosulfate is administered 4 to 8 hours after cisplatin,13-20 and that the ... be treated with cisplatin alone, they represent an WebSep 20, 2024 · Efficacy was evaluated in two multicenter open-label, randomized controlled trials in pediatric patients undergoing treatment with cisplatin-based chemotherapy for …
WebJun 13, 2024 · Cisplatin was the first platinum compound to gain approval by the US Food and Drug Administration (FDA), in 1978. Its mechanism of action is through its ability to bind to DNA, via purine base crosslinking, … WebFeb 15, 2024 · Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma Authors Wu Lin 1 2 , Jiong Qian 3 , Haohao Wang 1 , Ling Ren 2 , Yan Yang 1 , Chuanzhi Chen 1 , Xiangliu Chen 1 , Yingying Huang 1 , Jin Liu 1 , Nong Xu 3 , Lisong Teng 1 Affiliations
WebCisplatin and nimotuzumab combined with concurrent chemoradiotherapy is safe and effective in the treatment of locally advanced cervical cancer, both local tumor control and PFS rate are excellent, and the patient's tolerance is good, so it …
WebJul 3, 2024 · These include blockade of cisplatin entry into the cochlear fluid or hair cells. Further, antioxidants are among the most extensively studied agents due to the importance of ROS in ototoxicity. However, a concern exists that the chemotherapeutic efficacy of cisplatin may be reduced (Block et al., 2009). Reductions in inflammatory cytokine ... grammarly download for pc offlineWebCisplatin is a widely used cytotoxic agent approved in the treatment of bladder, ovarian, testicular, cervical, head and neck, and nonsmall cell lung cancer [ 1 – 3 ]. Cisplatin was first documented in 1847 by M. Peyrone, and it was approved by FDA for a variety of cancers in 1978. china restaurant lin bad oeynhausenWebOct 5, 2014 · Cisplatin is cleared by the kidney by both glomerular filtration and tubular secretion (Yao, Panichpisal et al., 2007; Ishida, Lee et al., 2002) Cisplatin … grammarly download for windowWebApr 15, 2024 · A 64-year-old man exhibited lack of efficacy during treatment with pirarubicin, gemcitabine and cisplatin for metastatic, high-grade non-muscle invasive … grammarly download for google chromeWebJul 30, 2024 · In this study, we proposed a comprehensive TME modulation strategy that modifies multiple elements of the TME in order to enhance cisplatin anticancer efficacy. To do so, we prepared biocompatible lipid-coated CaO 2 /cisplatin nanoparticles (LipoCaO 2 /DDP) by the reverse microemulsion method. china restaurant lee ho fook norderstedtWebThe efficacy of cisplatin must be improved for the treatment of UTUC because most patients with UTUC are older and may have renal insufficiency. The inadequate dose of cisplatin consequently leading to a poor outcome is a clinical challenge. grammarly download for officeWebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have … grammarly download for laptop free